Interventional Vascular Consumables Market to Hit $5.48B by 2030

NEW YORK - March 4, 2025 - PRLog -- According to the latest market research study published by P&S Intelligence, the global interventional vascular consumables market is poised for significant growth, with projected revenues increasing from $4,326.3 million in 2024 to $5,481.1 million by 2030, reflecting a compound annual growth rate (CAGR) of 4.0%.

This upward trend is largely driven by the escalating prevalence of cardiovascular diseases (CVDs), which account for approximately 32% of all global deaths, equating to around 17.9 million fatalities annually. The growing preference for minimally invasive procedures, especially among the aging population, is further propelling market expansion. These procedures are favored due to their reduced pain, lower risk, cost-effectiveness, and quicker recovery times compared to traditional open surgeries. Additionally, technological advancements and the introduction of innovative interventional devices are enhancing the efficacy and safety of vascular interventions, thereby boosting market growth.

Key Insights

Product Segmentation

Catheters are anticipated to maintain the largest market share, accounting for 35% in 2024. This dominance is attributed to their higher prices relative to other consumables, frequent usage, and the availability of various catheter types in the market. The presence of established players actively launching new products also supports this segment's growth. Notably, the inferior vena cava (IVC) filter category is expected to witness the highest CAGR of 4.6% during the forecast period.

Browse detailed report analysis on "Interventional Vascular Consumable Industry Trends and Future Analysis (https://www.psmarketresearch.com/market-analysis/interven...)"

Regional Trends

North America is projected to hold the largest market share, accounting for 45% in 2024. This is primarily due to rising healthcare expenditures, an increasing number of chronic disease cases, and a growing geriatric population in the region. Conversely, the Asia-Pacific region is expected to experience the fastest growth, driven by improving healthcare infrastructure, a large patient pool, and heightened awareness of minimally invasive procedures.

Technological Advancements

The market is witnessing significant technological innovations, including the development of advanced imaging techniques and the integration of artificial intelligence (AI) in interventional procedures. These advancements enhance the precision and safety of vascular interventions, leading to better patient outcomes and increased adoption of interventional consumables.​​

Emerging Opportunities

The increasing prevalence of CVDs, coupled with a rising geriatric population, presents substantial growth opportunities for market players. Additionally, the expanding adoption of minimally invasive procedures in emerging economies offers a lucrative market for interventional vascular consumables. Government initiatives aimed at improving healthcare infrastructure and increasing awareness about early disease diagnosis and treatment further support market expansion.